Cargando…
Therapeutic efficacy of Sunitinib and other broad spectrum receptor tyrosine kinase inhibitors (RTKI) in bleomycin-induced pulmonary fibrosis
Autores principales: | Knoerzer, D, Baginski, T, Wade, K, Fan, C, Rapp, S, Regina, K, Shih, F, Burney, M, Rouw, S, Welsch, D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3750855/ http://dx.doi.org/10.1186/1476-9255-10-S1-P38 |
Ejemplares similares
-
Immune Mechanisms of Pulmonary Fibrosis with Bleomycin
por: Ishida, Yuko, et al.
Publicado: (2023) -
Panax notoginseng Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice
por: Tsai, Kuen-Daw, et al.
Publicado: (2011) -
Broad-Spectrum Regulation of Nonreceptor Tyrosine Kinases by the Bacterial ADP-Ribosyltransferase EspJ
por: Pollard, Dominic J., et al.
Publicado: (2018) -
Cross-resistance to clinically used tyrosine kinase inhibitors sunitinib, sorafenib and pazopanib
por: Gotink, Kristy J., et al.
Publicado: (2015) -
Scanning electron microscopic study of capillary change in bleomycin-induced pulmonary fibrosis.
por: Kwon, K. Y., et al.
Publicado: (1991)